Content area

Abstract

Abstract

Anti-methamphetamine advertisements typically adopt a shock, fear, and repulse approach with the hopes of scaring people away from using drugs. This approach is typified by Faces of Meth and the Meth Project campaigns. Unfortunately, such approaches tend to do little in the way of diverting people away from using methamphetamine (meth) and may instead contribute to further stigmatization of those who use. Gaining an understanding of  how these ads are perceived by those who use meth can provide insight into more effective strategies to reduce meth use and its harms. We used photo-elicitation interviews with 47 people who used meth (30 former and 17 active). Specifically, we presented participants with images from the Faces of Meth and the Montana Meth Project campaigns to stimulate discussions about what makes good anti-drug ads. We found that participants think that the ads should reflect the reality of drug use, including harms relating to physical and mental health, legal status, and familial relationships. However, they also believe that the ads should offer hope and facilitate support and redemption. Insights from participants support reintegrative shaming approaches to designing anti-drug ads. Specifically, they suggest that the ads should tell authentic stories of hope to avoid further stigmatizing drug use.

Details

Title
Designing Anti-Meth Ads: Insights from those who use Methamphetamine
Author
Leban, Lindsay 1 ; Copes, Heith 1 ; Velazquez-Mondragon, Denis 2 

 University of Alabama at Birmingham, Department of Criminal Justice, Birmingham, USA (GRID:grid.265892.2) (ISNI:0000000106344187) 
 University of Richmond, Richmond, USA (GRID:grid.267065.0) (ISNI:0000 0000 9609 8938) 
Pages
638-650
Publication year
2022
Publication date
Aug 2022
Publisher
Springer Nature B.V.
ISSN
10662316
e-ISSN
19361351
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2748911043
Copyright
© Southern Criminal Justice Association 2022. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.